Clinical Trial Update: Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme

View source ↗

Summary

A completed clinical trial evaluating whether [11C]-Methionine PET/MRI can tailor postoperative radiochemotherapy for glioblastoma multiforme.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Snippet

Sponsor: Technische Universität Dresden | Conditions: Glioblastoma Multiforme | Status: COMPLETED